ArticleHuman vaccines & immunotherapeutics2014

Immunogenicity and safety of 13-valent pneumococcal conjugate vaccine when administered to healthy Japanese adults aged ≥50 years. An open-label trial.

Masanari Shiramoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.